Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
HW.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
HW.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HW.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HW.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HW.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used